vascular-surgery-2018-posters-abstracts

Page 107

May 24-25, 2018

London, UK

Vascular Surgery 2018

Edition of World Congress & Exhibition on

Vascular Surgery

Journal of Vascular and Endovascular Therapy

ISSN: 2573-4482

he aim of our study was to report our experience regarding

the safety, efficacy of duplex-guided polidocanol (POL) foam

sclerotherapy on the overall status of signs and symptoms in

patients with venous malformations (VMs). Thirty-seven patients

with symptomatic extratruncular VMs were treated with duplex-

guided POL foam sclerotherapy using Tessari’s method. Twenty-

five patients had limited VMs, while twelve had infiltrating VMs.

Postsclerotherapy surveillance was done 6 months after the

last sclerotherapy session and comprised both clinical and

duplex evaluation. Clinical evaluation entailed a patient self-

assessment questionnaire using a four-point scale to rate the

degree of symptoms improvement as follows: disappeared,

decreased, worsened, or recurred. Findings obtained by duplex

scanning were divided into four groups: 1) disappeared group;

2) partially recanalized group; 3) totally recanalized group; and 4)

worsened group. There were 20 males and 17 females with mean

age of 22.8±5.5 years. There was a significant reduction in the

total amount of POL (P=0.0037), the number of sclerotherapy

sessions was significantly lesser (P=0.0019), and treatment

success was significantly higher (P=0.0495) in patients with

limited VMs in comparison to those with infiltrating VMs. No

major complications related to sclerotherapy were encountered

in both groups. Polidocanol foam sclerotherapy is effective, and

safe for treatment of VMs, with high success rate and low risk

of major complications. Although associated with relatively high

recurrence rate compared with ethanol sclerotherapy, this can

be overcome by additional treatment sessions, given the relative

simplicity, speed, and safety.

Efficacy and safety of duplex-guided polidocanol foam

sclerotherapy for venous malformations

Walid Mohammed

South Valley University, Egypt

J Vasc Endovasc Therapy 2018, Volume 3

DOI: 10.21767/2471-8084-C1-003